findmyKOL
Clinical trialNCT01829568Active, not recruitingPhase 1Interventional

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

SponsorNational Cancer Institute (NCI)Enrollment33Ann Arbor Stage II Grade 1 Contiguous Follicular LymphomaAnn Arbor Stage II Grade 1 Non-Contiguous Follicular LymphomaAnn Arbor Stage II Grade 2 Contiguous Follicular LymphomaAnn Arbor Stage II Grade 2 Non-Contiguous Follicular LymphomaAnn Arbor Stage II Grade 3 Contiguous Follicular LymphomaAnn Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma+6 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Medstar Georgetown University Hospital

    Washington D.C., District of Columbia, United States

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, United States

  • Nyp/weill Cornell Medical Center

    New York, New York, United States

  • Unc Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, United States

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jun 2013
Primary completion
11 May 2015
Completion
6 Jun 2027
Last update posted
25 Jun 2026
Registered enrollment
33
Registry id
NCT01829568
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.